CF101

Pipeline Setback at Can-Fite BioPharma, Shares Down
Yahoo/Zacks.com
Tue, 12/31/13 - 11:31 am
Can-Fite BioPharma
CF101
OphthaliX’s dry eye drug fails endpoint in Phase III study
Pharmaceutical Business Review
Mon, 12/30/13 - 12:10 pm
OphthaliX
dry eye disease
CF101
OphthaliX Inc. Announces the Completion of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study
Yahoo/PR Newswire
Sat, 03/16/13 - 10:44 am
OphthaliX
CF101
dry eye disease